The Mechanism of APOBEC3B in Hepatitis B Virus Infection and HBV Related Hepatocellular Carcinoma Progression, Therapeutic and Prognostic Potential
Infection and Drug Resistance · 2024-10 · Volume 17 · 4477-4486
DOI: 10.2147/idr.s484265 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infection and Drug Resistance, 2024-10. Verfasst von Xiaochen Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Inn…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The…
Zitieren
APA
Yang, X., Wang, H., & Yu, C. (2024). The Mechanism of APOBEC3B in Hepatitis B Virus Infection and HBV Related Hepatocellular Carcinoma Progression, Therapeutic and Prognostic Potential. Infection and Drug Resistance, Volume 17, 4477-4486. https://doi.org/10.2147/idr.s484265
Vancouver
Yang X, Wang H, Yu C. The Mechanism of APOBEC3B in Hepatitis B Virus Infection and HBV Related Hepatocellular Carcinoma Progression, Therapeutic and Prognostic Potential. Infection and Drug Resistance. 2024;Volume 17:4477-4486. doi:10.2147/idr.s484265
BibTeX
@article{Yang2024,
author = {Yang, Xiaochen and Wang, Huanqiu and Yu, Chengbo},
title = {The Mechanism of APOBEC3B in Hepatitis B Virus Infection and HBV Related Hepatocellular Carcinoma Progression, Therapeutic and Prognostic Potential},
journal = {Infection and Drug Resistance},
year = {2024},
volume = {Volume 17},
pages = {4477--4486},
doi = {10.2147/idr.s484265}
}
EUVIMED